Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Prosper TX, Tyler TX, Austin TX, Cedar Park TX,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase2, Phase3, Recruiting
Severe Label Expansion for EVO Products Trial
for
Obstructive Sleep Apnea
Location: Dallas TX, New York NY
Sponsor: ProSomnus Sleep Technologies
Sex: All
Age: 18 - 70+
Code: NCT07090395
Recruiting
Reiterative Development and Evaluation Study of OSA Therapy System
for
Obstructive Sleep Apnea
Location: Dallas TX, Atlanta GA, Louisville KY, Columbia SC,
Sponsor: ApniCure, Inc.
Sex: All
Age: 18 - 70+
Code: NCT01634074
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
for
Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Location: Arlington TX, Plano TX, Houston TX, Houma LA,
Sponsor: Mercator MedSystems, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04862468
Phase2, Recruiting
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
for
Arthritis, Psoriatic
Location: Colleyville TX, Austin TX, Baytown TX, Lake Charles LA,
Sponsor: MoonLake Immunotherapeutics AG
Sex: All
Age: 18+
Code: NCT06641089
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Location: Dallas TX, Shreveport LA, Houston TX, Kansas City KS,
Sponsor: International Spine Study Group Foundation
Sex: All
Age: 18+
Code: NCT04194138
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
for
Narcolepsy Type 1
Location: Dallas TX, Frisco TX, Sugar Land TX, San Antonio TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07540897
Phase3, Recruiting
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Dallas TX, Austin TX, Houston TX, Sugar Land TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 70
Code: NCT07598708
Phase2, Phase3, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Fort Worth TX, Houston TX, Plantation FL, Tamarac FL,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase1, Phase2, Recruiting
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Dallas TX, Houston TX, Little Rock AR, Maitland FL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06786624
Phase3, Recruiting
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Location: Dallas TX, Fort Worth TX, Birmingham AL, Nashville TN,
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All
Age: 18+
Code: NCT07298473
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Allen TX, Corpus Christi TX, Atlanta GA, Tampa FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07332481
Phase3, Recruiting
The PERSEVERE Study
for
Pulmonary Embolism, Pulmonary Thromboembolism
Location: Dallas TX, San Antonio TX, Jackson MS, Nashville TN,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT06588634
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE),
Location: Arlington TX, Colleyville TX, Allen TX, Memphis TN,
Sponsor: Ventus Therapeutics U.S., Inc.
Sex: All
Age: 18 - 70+
Code: NCT07260877
Phase2, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)